Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=167582e4-7aaa-4587-a368-317d55626b7a&Preview=1 Date 3/16/2011 Company Name NxThera Mailing Address 4186 Lexington Ave. St. Paul, MN 55126 Company Description NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. … Continue reading “NxThera Obtains $12,600,000 Series B Round”
Tag: Arboretum Ventures
Accuri Generates Windfall for Plymouth Ventures, But Not University of Michigan
Plymouth Ventures Partners stands to cash out big from Becton, Dickinson’s (NYSE:[[ticker:BDX]]) pending acquisition of Accuri Cytometers in Ann Arbor, MI. But the University of Michigan, where the technology originated? Uh…not so much. Plymouth was one of Accuri’s first investors when the company spun out of the university in 2005, providing around $2 million in … Continue reading “Accuri Generates Windfall for Plymouth Ventures, But Not University of Michigan”
Arboretum Ventures in Ann Arbor Seeks Greener Pastures With New $125M Fund
Arboretum Ventures is gonna need a bigger garden. The early stage investment firm, based in Ann Arbor, MI, plans to raise a new $125 million fund, its third in so many years, according to SEC documents. The company previously pulled together $73 million and $24 million for its first two funds. Arboretum, which specializes in … Continue reading “Arboretum Ventures in Ann Arbor Seeks Greener Pastures With New $125M Fund”
Ann Arbor redux: Becton Dickinson and Co. buys medtech startup Accuri Cytometers
Treja-vu! Becton, Dickinson and Company (NYSE:[[ticker:BDX]]) announced Monday it will acquire Accuri Cytometers in Ann Arbor, MI, for an undisclosed amount. Accuri, which makes devices that can count cells and chromosomes, is led by Jeff Williams and backed by Arborteum Ventures in Ann Arbor. If this trio sounds familiar, it should. HandyLabs, another Ann Arbor-bred … Continue reading “Ann Arbor redux: Becton Dickinson and Co. buys medtech startup Accuri Cytometers”
The Story of Detroit Added Some Significant Chapters in 2010; Here Are 10 of Them
When Xconomy Detroit launched in April 2010, I wrote that this city is a verb, in a constant state of action, of “becoming,” of striving for something greater. Having lived in Michigan for much of my life, I can say that this was true even in good times, and certainly even more so in bad. … Continue reading “The Story of Detroit Added Some Significant Chapters in 2010; Here Are 10 of Them”
Arboretum Invests in Pathology Company
Arboretum Ventures, based in Ann Arbor, MI, is a co-leader in a $10-million Series B financing round for Irvine, Calif.-based PathCentral, an anatomic pathology services company, according to a report today in peHUB. PathCentral says the money will be used to enhance its web-based laboratory information system, among other things. Joining Arboretum in the round … Continue reading “Arboretum Invests in Pathology Company”
PathCentral Receives $10,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1144f34f-f33a-4f97-af3a-c6abd98a62e1&Preview=1 Date 11/2/2010 Company Name PathCentral Mailing Address 213 Technology Dr. Irvine, CA 92629 Company Description PathCentral is the first and only company to provide all the tools required by community pathology practices to increase revenues, improve operating efficiencies, and ensure patient safety, in a single integrated and affordable platform. Website http://www.pathcentral.net … Continue reading “PathCentral Receives $10,000,000 Series B Round”
Michigan Venture Funds: A List of Recent Closings and Firms Raising Money Now
It’s not exactly a secret that this isn’t the greatest time for venture capital. Returns over the past decade have gone negative after the heady dotcom bubble years, and with the recession lingering many funds have either closed or found themselves significantly smaller as it became harder and harder to attract capital. These national trends … Continue reading “Michigan Venture Funds: A List of Recent Closings and Firms Raising Money Now”
Michigan’s Renaissance “Fund of Funds” Closes at Nearly $50M, Ready to Make Connections Between VCs and Entrepreneurs
To Chris Rizik, one of the best things about yesterday’s announced final close of nearly $50 million in investment funds for the Renaissance Venture Capital Fund is that the money comes with no government strings attached. “There’s not one government dollar in this,” says Rizik, CEO of the Detroit and Ann Arbor, MI-based “fund of … Continue reading “Michigan’s Renaissance “Fund of Funds” Closes at Nearly $50M, Ready to Make Connections Between VCs and Entrepreneurs”
Accuri Cytometers Raises $6M for Smaller, Cheaper Cell Analysis Instruments
[Updated: 11:40 am] Accuri Cytometers, the Ann Arbor, MI-based company with a vision of making high-powered cell analysis machines cheaper and more accessible to biology labs, has raised $6 million in new venture capital. The financing was disclosed Friday in a filing with the Securities & Exchange Commission. [Updated with list of investors] Fidelity Biosciences, … Continue reading “Accuri Cytometers Raises $6M for Smaller, Cheaper Cell Analysis Instruments”
Accuri Cytometers Obtains $6,000,000 Series E Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f32382b5-2884-4164-878d-d744c83c5358&Preview=1 Date 7/12/2010 Company Name Accuri Cytometers Mailing Address 173 Parkland Plaza Ann Arbor, MI 48103 Company Description Accuri Cytometers Inc. is an Ann-Arbor based life sciences company developing revolutionary high performance cell analysis systems designed to bring the power of flow cytometry into the labs of life sciences researchers everywhere. Reflecting … Continue reading “Accuri Cytometers Obtains $6,000,000 Series E Round”
Uptake Medical Raises $17.5M for Emphysema Device
Uptake Medical has closed a financing round worth $17.5 million. The Seattle-based company says it will use the money to get clearance to start selling a device to treat emphysema in Europe, to start marketing it outside the U.S., and to pursue FDA approval. The Series B financing was led by Maverick Capital, and included … Continue reading “Uptake Medical Raises $17.5M for Emphysema Device”
Uptake Medical Corp Obtains $17,500,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d9e6303f-4291-4e19-ae64-e67d6614497c&Preview=1 Date 7/7/2010 Company Name Uptake Medical Corp Mailing Address 1924 1st Avenue 3rd Floor Seattle, WA 98101 Company Description Uptake Medical Corporation is a Seattle-based medical device company dedicated to improving the lives of patients suffering from emphysema and other types of chronic obstructive pulmonary diseases (COPD). Website http://www.uptakemedical.com/ Transaction Type … Continue reading “Uptake Medical Corp Obtains $17,500,000 Series B Round”
All-Michigan VC Team Helps Bring State-Grown Medical Imaging Technology to Market
There are three reasons Michigan can feel good about a recent $8 million venture capital investment in Detroit-based medical imaging company Delphinus Medical Technologies. It is an investment in a Michigan company; The investment comes from an all-Michigan VC team; It is an investment in Michigan-grown technology developed in one of the state’s premier research … Continue reading “All-Michigan VC Team Helps Bring State-Grown Medical Imaging Technology to Market”
Delphinus Medical Technologies Lands $8,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d36f757f-bfa0-4c2c-9a39-d103d82a5103&Preview=1 Date 5/25/2010 Company Name Delphinus Medical Technologies Mailing Address Hudson-Webber Cancer Research Center Detroit, MI 48201 Company Description Delphinus Medical Technologies, LLC., is a Michigan company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates … Continue reading “Delphinus Medical Technologies Lands $8,000,000 New Round”
Mirabilis Nabs $1M for Ultrasound
Mirabilis Medica, the Bothell, WA-based developer of ultrasound technology to treat uterine fibroids, has raised $1 million in debt and options out of a financing round that could be worth $2 million, according to a regulatory filing. This company, which Xconomy profiled last June, said last year it had raised $11 million since inception from … Continue reading “Mirabilis Nabs $1M for Ultrasound”
NXThera Secures $3,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0753911-4a9c-4c1c-bd72-f03c01ed84e2&Preview=1 Date 12/31/2009 Company Name NXThera Mailing Address 350 Sharon Park Drive Menlo Park, CA 94025 Company Description The company develops medical devices. Website Undisclosed Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Arboretum Ventures
Mirabilis Medica Aims to Help Women Avoid the Dreaded Hysterectomy
It only takes about 30 minutes from downtown Seattle to get to what some people like to call the “Silicon Valley of Ultrasound,” in Bothell, WA. So when I heard about another ultrasound startup company, one with a name that comes from the Latin word for “miraculous,” I figured it was worth checking out. There’s … Continue reading “Mirabilis Medica Aims to Help Women Avoid the Dreaded Hysterectomy”
Uptake Medical Raises $3M in Venture Capital
Uptake Medical, a Seattle-based medical device company, has raised $3 million to carry out a pair of small clinical trials that could show it has a viable technique for treating emphysema, and other deadly lung-obstructing diseases. The company got the cash as a “bridge” financing to carry out trials in Australia and Germany, which should … Continue reading “Uptake Medical Raises $3M in Venture Capital”
VasoNova Obtains $10,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb2ac099-5ef8-4ee4-ab72-30f002b7fe71&Preview=1 Date 9/16/2008 Company Name VasoNova Mailing Address 1368 Bordeaux Street Sunnyvale, CA 94089 Company Description The company operates as a medical device development company. Website http://www.vasonova.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Aphelion Capital, LLC … Continue reading “VasoNova Obtains $10,000,000 Series B Funding”
NXThera Receives $3,200,100 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=001a6d1e-7b3d-4878-8760-82a5c73360a5&Preview=1 Date 6/30/2008 Company Name NXThera Mailing Address 350 Sharon Park Drive Menlo Park, CA 94025 Company Description The company develops medical devices. Website Undisclosed Transaction Type Venture Equity Transaction Amount $3,200,100 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Aberdare Ventures Venture Investor Arboretum Ventures … Continue reading “NXThera Receives $3,200,100 New Financing”